Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1
Figure 1.The HPLC analysis of SMY and its main components, including 5-HMF (1), lobetyolin (2), Schisandrin B (3), schizandrin (4). (A) Standards. (B) Samples.